Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Bringing Nuclear Risk Reduction to the Digital Generation
Younger generations understand nuclear weapons through digital screens rather than personal experience. The future of nuclear risk reduction hinges on the ability to communicate with and engage young people directly; to educate and mobilize them around nuclear issues.
Jake Jordan, PhD serves as the Vice President of Global Biological Policy and Programs (NTI | bio). He rejoined NTI in March 2026, having previously served as a senior director from 2018 to 2020. Jake spoke with NTI | bio intern Alex Kyabarongo about his role and past experiences.
AI Can Design New Proteins. It’s Time to Build Real Biosecurity Guardrails
As protein design tools and other biological AI models become more capable of designing novel biological components and systems, the mechanisms to prevent misuse have not kept pace.
Tracking Health Security Progress and Building Resilience in Africa
The AHS Index is an objective, evidence-based tool that helps countries and organizations set priorities and identify where investments can have the greatest impact. As health threats become more complex and interconnected, maintaining momentum will require sustained investment, stronger partnerships, and continued political commitment.
Africa Making Progress on Health Security; Sustained Actions & Investment Are Essential
African countries are building stronger systems to advance health security and sovereignty. However, the scale and speed of rising health threats call for urgent action and increased investment.
A Simple Step to Close a Dangerous Biosecurity Gap
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.
Leading with Science and Evidence in a Time of Retreat
As global resources become more constrained, evidence-based tools that guide investments toward maximum impact are more important than ever. This World Health Day, the WHO urges the world to embrace evidence, support science-led solutions, and advance global cooperation to turn evidence into action.
Disney Channel’s The Luck of the Irish reminds us that failing to safeguard a powerful asset—whether a magical lucky coin or advanced emerging technology—can lead to disaster. Strengthening AIxBio governance is about building guardrails to accelerate innovation and safeguards to prevent harm.
The convergence of artificial intelligence and the life sciences is reshaping what’s possible in biology, delivering major advances–ranging from accelerating vaccine discovery to advancing new tools for mitigating the effects of climate change–and new risks. NTI | bio’s AIxBio Horizon Scan looks ahead to where AIxBio capabilities are headed over the coming years.